Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Prescription law change requires ID number
Syringe
Until now, practitioners have not been required to include a unique identification code when prescribing Schedule 2 and 3 controlled drugs.
Vets to include RCVS number when prescribing Schedule 2 and 3 drugs

Veterinary practitioners prescribing Schedule 2 and 3 controlled drugs will soon be required to include their RCVS registration number on the prescription.

The amendment to the Misuse of Drugs Regulations 2001, which comes into force on 1 July 2015, is set to bring the veterinary sector in line with the private human healthcare sector.

A government circular states that the change will improve the ability to collate data on individual prescribing activity for the veterinary sector for monitoring when required.

Since 2007, human healthcare professionals have been required to include their unique identification number on prescriptions.

The change was brought about by the Shipman Inquiry, a report produced by a British government investigation into the activities of general practitioner and serial killer Harold Shipman.

Veterinary prescriptions are private and, until now, practitioners have not been required to include a unique identification code when prescribing Schedule 2 and 3 controlled drugs.

The full circular of changes to the Misuse of Drugs Regulations 2001 can be found at www.gov.uk

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'